The expression of mTOR in glioma samples was higher combined with normal brain tissues and increased with the increasing degree of malignancy in glioma (low-grade glioma vs. high-grade glioma, P < 0.01; Fig. 1b). This evidence concerns the gene MTOR and central nervous system cancer.